Daily Cosmetic Research Analysis
Evidence synthesis in cosmetic medicine highlights that microneedling plus tranexamic acid does not outperform other melasma therapies overall, though it exceeds microneedling alone. A systematic review shows time-driven activity-based costing can pinpoint major cost drivers in plastic surgery, enabling value-based care. Laboratory analysis reveals measurable mercury in consumer cosmetic clays, underscoring the need for routine metal testing and regulatory oversight.
Summary
Evidence synthesis in cosmetic medicine highlights that microneedling plus tranexamic acid does not outperform other melasma therapies overall, though it exceeds microneedling alone. A systematic review shows time-driven activity-based costing can pinpoint major cost drivers in plastic surgery, enabling value-based care. Laboratory analysis reveals measurable mercury in consumer cosmetic clays, underscoring the need for routine metal testing and regulatory oversight.
Research Themes
- Evidence-based aesthetic dermatology therapies
- Value-based care and cost measurement in plastic surgery
- Cosmetic product safety and heavy metal contamination
Selected Articles
1. Combining Microneedling and Tranexamic Acid for Melasma: A Systematic Review and Meta-Analysis.
Across studies, microneedling plus tranexamic acid did not outperform other melasma treatments overall but was superior to microneedling alone. Patient satisfaction and adverse events were comparable to alternatives, supporting MN+TXA as a reasonable option when microneedling is planned.
Impact: This meta-analysis clarifies the role of MN+TXA in melasma by separating its benefit over MN alone from equivalence versus broader therapies, guiding evidence-based counseling and protocol design.
Clinical Implications: When considering microneedling for melasma, adding topical/intradermal TXA can improve outcomes versus MN alone, but it should not be assumed superior to established modalities (e.g., hydroquinone, lasers). Standardization of depth, sessions, and TXA dosing is needed.
Key Findings
- Overall, MN+TXA showed no significant superiority over other melasma treatments in pooled analyses.
- Subgroup analysis demonstrated MN+TXA was significantly more effective than microneedling alone.
- Patient satisfaction and adverse event rates were similar between MN+TXA and alternative therapies.
- Risk of bias was appraised using RoB 2.0/ROBINS-I, and outcomes were synthesized with SMD and 95% CI.
Methodological Strengths
- PRISMA-compliant systematic review and meta-analysis with standardized effect size synthesis.
- Formal risk-of-bias assessment using RoB 2.0 and ROBINS-I, plus subgroup analyses.
Limitations
- Heterogeneity in microneedling parameters (needle depth, session number) and TXA dosing/routes.
- Inclusion of nonrandomized studies and small sample sizes may limit precision and generalizability.
Future Directions: Conduct multicenter, adequately powered RCTs with standardized MN parameters and TXA regimens, directly comparing MN+TXA versus hydroquinone, lasers, and oral/intradermal TXA alone.
BACKGROUND: Tranexamic acid (TXA) has been explored as a potential treatment for melasma, and microneedling (MN) enhances transcutaneous drug delivery. To evaluate the clinical efficacy, patient satisfaction, and safety of microneedling combined with TXA (MN + TXA) in treating melasma compared to alternative treatment modalities. METHODS: A systematic review and meta-analysis were conducted following PRISMA guidelines. Clinical improvement, patient satisfaction, and adverse events were analyzed using standardized mean differences (SMD) with 95% confidence intervals (CI). The risk of bias was assessed using the RoB 2.0 and ROBINS-I tools. RESULTS: MN + TXA showed no significant improvement over other treatments in overall clinical outcomes. However, subgroup analysis revealed MN + TXA was significantly more effective than MN alone. Patient satisfaction did not significantly differ between MN + TXA and other treatments. The incidence of adverse events was similar across treatment groups. CONCLUSION: Compared to other therapies, MN+TXA may be considered a potential option for melasma management. Future large-scale, standardized, multicenter trials directly are essential to confirm its efficacy, safety, and clinical utility. LEVEL OF EVIDENCE I: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
2. Optimizing Costs in Plastic Surgery: A Systematic Review of Time-driven Activity-based Costing Applications.
Across 17 studies, TDABC consistently identified operating room time, staffing, and postoperative care (including preventable ICU utilization) as primary cost drivers in plastic surgery. Targeted strategies such as workflow standardization, task shifting to lower-cost personnel, and optimized postoperative pathways can reduce costs without compromising quality.
Impact: Introduces an actionable costing methodology tailored to plastic surgery, enabling value-based care and informing practice redesign for both reconstructive and cosmetic procedures.
Clinical Implications: Implement TDABC mapping to quantify stepwise resource use, shorten OR time, avoid non-essential ICU admissions, and reassign tasks (e.g., pre/postoperative education, dressing changes) to cost-effective roles.
Key Findings
- Seventeen studies applied TDABC/costing methods to plastic surgery, identifying OR time, staffing, and postoperative care as primary cost drivers.
- Inefficiencies included prolonged OR times and unnecessary ICU stays; cost savings arose from optimized postoperative care and task shifting.
- TDABC provides granular, process-level insight to target specific cost-reduction opportunities without degrading quality.
Methodological Strengths
- Systematic literature search with explicit inclusion criteria capturing empirical cost drivers.
- Use of TDABC frameworks that map entire care cycles for reproducible resource accounting.
Limitations
- Heterogeneity across institutions in costing methods and pathways limits meta-analysis and generalizability.
- Predominantly single-center, retrospective TDABC implementations with limited linkage to clinical outcomes.
Future Directions: Prospective, multicenter TDABC studies in cosmetic procedures with standardized pathways and concurrent outcome measures (complications, PROs) to quantify value.
BACKGROUND: The rising complexity and cost of healthcare in plastic surgery, particularly in resource-intensive procedures like free flap and breast reconstruction, pose significant financial challenges. Time-driven activity-based costing (TDABC) offers a method to accurately assess these costs by mapping each step of the care cycle based on time and resources consumed. Although TDABC has been utilized in high-cost fields such as neurosurgery and spine surgery, its application in plastic surgery remains underexplored. This systematic review evaluates the literature on TDABC use in plastic surgery to identify key cost drivers and propose strategies for cost-efficiency. METHODS: A systematic review was conducted on studies applying TDABC, activity-based costing, and cost-to-charge ratio in plastic surgery, sourced from PubMed. Inclusion criteria focused on peer-reviewed studies from the last decade assessing costing strategies in aesthetic and reconstructive plastic surgery, resulting in 17 studies that provided empirical data on cost drivers and resource allocation. RESULTS: Operating room time, staffing, and postoperative care are identified as primary cost contributors in complex reconstructive surgery, with TDABC highlighting inefficiencies such as prolonged operating room time and unnecessary intensive care unit stays. Cost-saving opportunities were found in optimizing postoperative care and reallocating tasks to lower-cost personnel. CONCLUSIONS: TDABC provides a framework for cost optimization in plastic surgery by offering granular insights into resource utilization, allowing for targeted interventions that reduce expenses without compromising care quality. Future research should explore the application of TDABC to cosmetic procedures and assess its long-term cost-effectiveness in plastic surgery.
3. Analysis of Mercury Concentration in Cosmetic Clays.
Mercury was detected in all tested cosmetic clay samples, averaging 28.91 µg/kg (range 1.87–200.81 µg/kg), with green and white clays showing the highest levels and purple/blue the lowest. Statistically significant differences by clay type and manufacturer highlight the need for routine metal testing and regulatory standards.
Impact: Provides quantitative safety data on mercury contamination in widely used cosmetic clays, directly informing consumer safety, clinician counseling, and regulatory policy.
Clinical Implications: Advise patients to avoid ingesting clays and to use reputable sources for topical products; consider heavy metal exposure in dermatitis or systemic complaints. Support policies mandating metal content testing and transparent labeling for cosmetic clays.
Key Findings
- All tested cosmetic clay samples contained mercury with a mean of 28.91 µg/kg (range 1.87–200.81 µg/kg).
- Green (AM 53.26 µg/kg) and white (AM 52.80 µg/kg) clays had the highest Hg concentrations; purple (AM 2.56 µg/kg) and blue (AM 3.69 µg/kg) the lowest.
- Differences in Hg content across clay types were statistically significant, indicating variability by composition and source.
- Analysis used validated atomic absorption spectrometry (AMA 254), sampling multiple manufacturers.
Methodological Strengths
- Use of atomic absorption spectrometry (AMA 254) for sensitive and validated Hg quantification.
- Comparison across multiple clay types and manufacturers with statistical testing.
Limitations
- Geographically restricted to products available in Poland; generalizability may be limited.
- Total Hg quantified without speciation or assessment of dermal bioavailability and human exposure risk.
Future Directions: Expand to multi-country sampling, include speciation and dermal/oral bioavailability studies, and integrate risk assessment to inform regulatory limits.
(1) Background: Clays are popular raw materials of natural origin used in cosmetology, beauty salons, and home care. They have moisturizing, soothing, cleansing, disinfecting, detoxifying, and regenerating properties, and can be used externally in the form of poultices or internally in solution form. Though they are characterized by a rich and diverse mineral composition and are considered safe for the body, their use can expose users to harmful elements including mercury. (2) Materials and methods: This study analyzed mercury (Hg) concentrations in samples of cosmetic clays available on the Polish market. Hg analysis was performed using the AAS method with an AMA 254 analyzer. The clays differed in type/color and were purchased from different manufacturers. (3) Results: The mean Hg content in all the tested samples was 28.91 µg/kg, with a range of changes of 1.87-200.81 µg/kg. The highest concentrations of Hg were found in green (AM = 53.26 µg/kg) and white (AM = 52.80 µg/kg) clays, while the lowest were detected in purple (AM = 2.56 µg/kg) and blue (AM = 3.69 µg/kg) clays. The differences in Hg content between individual types of clay were statistically significant. (4) Conclusions: Due to the presence of Hg found in all the samples of cosmetic clay tested, it is likely that these products need to be tested for their metal contents.